Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Fingolimod as a Treatment of Cerebral Edema After Intracerebral Hemorrhage

NCT04088630 is registered in ClinicalTrials.gov with Wake Forest University Health Sciences as lead sponsor.

NCT NCT04088630
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04088630 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Fingolimod as a Treatment of Cerebral Edema After Intracerebral Hemorrhage
Lead sponsor
Wake Forest University Health Sciences
Phase
Phase 1
Overall status
Completed
Start date
August 7, 2020
Completion date
June 5, 2024
Enrollment
28 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cerebral edema, intracerebral hemorrhage, intracerebral hemorrhage intraparenchymal, intracerebral hemorrhage, hypertensive, stroke hemorrhagic